首页> 外文期刊>Journal of Neuropathology and Experimental Neurology: Official Journal of the American Association of Neuropathologists, Inc >Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One With BRAF(V600E) Mutation and Clinical Response to the BRAF Inhibitor Dabrafenib
【24h】

Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One With BRAF(V600E) Mutation and Clinical Response to the BRAF Inhibitor Dabrafenib

机译:原发性脑膜多形性星形胶质细胞瘤具有间变性特征:2例报告,其中1例发生BRAF(V600E)突变,对BRAF抑制剂达布拉非尼有临床反应

获取原文
获取原文并翻译 | 示例
           

摘要

Primary meningeal gliomas are rare tumors composed of a heterogeneous group of neoplasms. We present 2 clinically aggressive cases of primary meningeal pleomorphic xanthoastrocytoma that clinically mimicked meningioma. One case presented in the posterior fossa of a 56-year-old woman; the other centered on the left operculum of a 35-year-old woman. These cases showed many of the classic features of pleomorphic xanthoastrocytoma, except that xanthomatous cells were rare and eosinophilic granular bodies were inconspicuous. Both cases exhibited high proliferative indices and superficially invaded the brain. One case harboring a BRAF(V600E) mutation disseminated to the thecal sac and showed a clinical response to the targeted BRAF inhibitor dabrafenib. These cases seem to represent an unusual primarily extra-axial presentation of pleomorphic xanthoastrocytoma and may account for at least some of the previously reported cases of primary meningeal glioma and/or glial fibrillary acidic protein-immunoreactive meningioma variants. We suggest that BRAF mutation analysis be considered in all meningeal lesions showing atypical histologic or immunohistochemical profiles, particularly those exhibiting glial differentiation, as a diagnostic aid and possible indication for targeted therapy.
机译:原发性脑膜神经胶质瘤是由异质性肿瘤组组成的罕见肿瘤。我们目前临床上模仿脑膜瘤的2原发性脑膜多形性黄体星形细胞瘤临床侵略性案例。 1例在56岁女性后颅窝中出现;另一个以一名35岁妇女的左眼为中心。这些病例显示了多形性黄体星形细胞瘤的许多经典特征,除了黄体细胞少见,嗜酸性粒状体不起眼。两种病例均表现出高增殖指数,并浅表侵入大脑。一例带有BRAF(V600E)突变的病例传播到了皮囊,并显示出对靶向BRAF抑制剂达布拉非尼的临床反应。这些病例似乎代表了多形性黄体星形细胞瘤的不寻常的主要轴向外表现,并且可能解释了至少一些先前报道的原发性脑膜神经胶质瘤和/或神经胶质原纤维酸性蛋白免疫反应性脑膜瘤变体。我们建议在所有表现出非典型组织学或免疫组织化学特征的脑膜病变中,尤其是那些表现出神经胶质分化的脑膜病变中,都应考虑进行BRAF突变分析,以作为诊断辅助和可能的靶向治疗。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号